2022 PharmaVoice 100 Celebration

The Next Era of Leadership


Virtual Event

On Demand


Lori Abrams
VP, Patient Advocacy & Clinical Research Diversity
Giacomo Chiesi
Head of Global Rare Diseases
Chiesi Global Rare Diseases
Stephen Dale
Chief Medical Officer
Kura Oncology
Mary-Ann Etiebet, MD
Associate VP of Health Equity
Merck & Co., Inc.
Jeff Fischer
Co-Founder and President
Longhorn Vaccines & Diagnostics
Simba Gill, PhD
Evelo Biosciences
Mike Gladstone
Global President of Inflammation & Immunology, Pfizer Inflammation & Immunology
Mark Goldberg, MD
Chairman and CEO
Sebastian Guth
President, Americas Region
Bayer Pharmaceuticals
LaQuinta Jernigan
Chief Operating Officer
Kim Johnson
Global CEO
Ogilvy Health
Otis Johnson, PhD
Chief Diversity, Inclusion and Sustainability Officer
Karin Jooss
Head of Research & Development
Gritstone Bio
Rachel Lenington
Chief Operating Officer
Athira Pharma, Inc.
Jeremy Levin, D.Phil,MB BChir
President & CEO
Ovid Therapeutics
Cristian Massacesi, MD
Chief Medical Officer and Oncology Chief Development Officer
Andrew Miller
Founder & Chief Operating Officer
Karuna Therapeutics
Jonathan Ng
CEO and Founder
Iterative Scopes
Melinda Richter
Global Head
JLABS, Johnson & Johnson
Amanda Ryan
G3 Life Sciences
Helen Sabzevari, PhD
President and CEO
Armon Sharei, PhD
Co-Founder and CEO
SQZ Biotech
Helen Thackray, MD
Chief Research and Development Officer
BioCryst Pharmaceuticals, Inc.
Barbara Wirostko, MD
Chief Medical Officer & Co-Founder
Qlaris Bio

The pandemic changed everything — requiring our PharmaVoice 100 honorees to pivot, be agile, develop new skills, and think about health equity and diversity in a different way. As the industry moves into a post-pandemic phase, there is no going back. The next era of leadership — from molecule to market — will be more focused on patients than ever before and ripe with opportunities for emerging science and talent.

Join PharmaVoice Editor in Chief Emeritus Taren Grom and industry leaders for a full-day event featuring engaging and interactive discussions with your peers and PharmaVoice 100 honorees, followed by a PharmaVoice 100 Celebration ceremony and more networking opportunities.

See below for more information on the sessions.

About PharmaVoice 100:

Our PharmaVoice publication developed the only awards program in the industry to recognize a diverse mix of people across a range of disciplines and ages — from the clinic to the C-suite — who are making meaningful contributions in their fields of influence. Since 2005, the PharmaVoice 100-- and Red Jacket honorees- have become one of the publication’s most anticipated features, and are determined by nominations submitted from colleagues and peers in the industry.

Watch Now

Field will not be visible to web visitor
Field will not be visible to web visitor
Field will not be visible to web visitor
Field will not be visible to web visitor

Event Powered By

Session Information

Welcome and CEO Roundtable: Navigating Uncharted Waters

Therapeutic Focus Session 1: The Future of Oncology

Therapeutic Focus Session 2: The Future of CNS

Entrepreneur Roundtable: Exploring New Possibilities

Championing a DE&I True North

Therapeutic Focus Session 3: Vaccines & Infectious Disease

Therapeutic Focus Session 4: Rare Disease

Embracing Health Equity

Keynote Presentation- Melinda Richter, Global Head, JLABS, Johnson & Johnson

PharmaVoice 100 Celebration: The Next Era of Leadership

Copyright 2022 Industry Dive | Privacy Policy | Terms of Use